Sargent Investment Group LLC grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 5.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 9,766 shares of the biopharmaceutical company’s stock after acquiring an additional 521 shares during the quarter. Sargent Investment Group LLC’s holdings […]
Qtron Investments LLC lessened its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 34.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,299 shares of the biopharmaceutical company’s stock after selling 6,883 shares during the period. Qtron Investments LLC’s holdings in […]
Princeton Capital Management LLC reduced its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 21.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,832 shares of the biopharmaceutical company’s stock after selling 2,426 shares during the period. Princeton Capital […]
Princeton Capital Management LLC reduced its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 21.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,832 shares of the biopharmaceutical company’s stock after selling 2,426 shares during the period. Princeton Capital […]
Princeton Capital Management LLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 21.5% in the third quarter, HoldingsChannel.com reports. The firm owned 8,832 shares of the biopharmaceutical company’s stock after selling 2,426 shares during the period. Princeton Capital Management LLC’s holdings in Bristol-Myers Squibb were worth $513,000 as of its […]